Levoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes

OBJECTIVE: This extended evaluation (EE) of the SONICS study assessed the effects of levoketoconazole for an additional 6 months following open-label, 6-month maintenance treatment in endogenous Cushing’s syndrome. DESIGN/METHODS: SONICS included dose-titration (150–600 mg BID), 6-month maintenance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Auchus, Richard J, Greenman, Yona, Zacharieva, Sabina, Geer, Eliza B, Salvatori, Roberto, Pivonello, Rosario, Feldt-Rasmussen, Ulla, Kennedy, Laurence, Buchfelder, Michael, Biller, Beverly MK, Cohen, Fredric, Heaney, Anthony P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716395/
https://www.ncbi.nlm.nih.gov/pubmed/36251618
http://dx.doi.org/10.1530/EJE-22-0506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716395/
https://www.ncbi.nlm.nih.gov/pubmed/36251618
http://dx.doi.org/10.1530/EJE-22-0506

Ejemplares similares